AMA demands suspension of high-THC medicinal cannabis
Medicinal cannabis clinics are 'flagrantly breaching' TGA guidelines, the AMA claims.
Doctors have “no reasonable justification” for prescribing medicinal cannabis that is 98% tetrahydrocannabinol, says the AMA, which wants these drugs suspended from the Special Access Scheme.
The AMA has used a TGA consultation on sharing Special Access Scheme data to demand a review of medicinal cannabis categories “and the complete removal of category 5 — products with a THC [tetrahydrocannabinol] content greater than 98% — while the review is conducted”.
